Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 2/2018

01-02-2018 | Clinical Investigation

Lysis-Assisted Balloon (LAB) Thrombectomy. A Declotting Technique for the Treatment of Thrombosed Arteriovenous Dialysis Grafts. 5-Year Experience of 241 Endovascular Procedures

Authors: Panagiotis M. Kitrou, Panagiotis Papadimatos, Stavros Spiliopoulos, Nicolaos Christeas, Konstantinos Katsanos, Dimitris Karnabatidis

Published in: CardioVascular and Interventional Radiology | Issue 2/2018

Login to get access

Abstract

Background

This is a retrospective single-center analysis investigating the results of a percutaneous lysis-assisted balloon (LAB) thrombectomy procedure for the treatment of thrombosed arteriovenous dialysis grafts (AVGs).

Materials and Methods

Within 5 years (January 2012–December 2016), 291 declotting procedures were performed for the treatment of thrombosed dialysis arteriovenous fistulas or grafts. Data were available for 129 patients (75 men, 58.1%) with an AVG, undergoing 241 procedures [1.87 procedures/patient (1–10)]. Procedure includes initial lysis with 5 mg recombinant tissue plasminogen activator followed by thrombectomy with a high-pressure balloon for thrombus maceration using “facing sheaths” technique. 61 patients had ≥ 2 declotting procedures. In 80 cases (80/241; 33.2%), a stent graft (SG) was used for treatment of persistent stenosis. Main primary outcome measures were clinical success and postintervention assisted primary patency (PAPP). Secondary outcome measures included procedural complications and investigation of independent factors that could influence circuit survival.

Results

Median PAPP was 434 days according to Kaplan–Meier survival analysis. Clinical success was 96.26%. In six cases (6/241, 2.49%) declotting failed and a catheter was placed. There were 16 minor (16/241, 6.64%) and no major complications. There was no significant difference in circuit survival regardless of SG use (No SG 406 days vs. SG 349 days; p = 0.24). There was a significant difference in favor of the second declotting compared to the first in 61 patients (first: 162 days vs. second: 447 days; p < 0.0001).

Conclusion

LAB thrombectomy resulted in high-circuit survival rates with increased technical success and minimum complications without the use of thrombectomy devices.
Literature
1.
Haskal ZJ, et al. Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA study. J Vasc Interv Radiol. 2016;27(8):1105–14.CrossRefPubMed
2.
Kitrou PM, et al. Paclitaxel-coated balloons for the treatment of dysfunctional dialysis access. Results from a single-center, retrospective analysis. Cardiovasc Intervent Radiol. 2017;40(1):50–4.CrossRefPubMed
3.
Kitrou PM, et al. Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial. J Vasc Interv Radiol. 2017;28(6):811–7.CrossRefPubMed
4.
Kitrou PM, et al. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84(3):418–23.CrossRefPubMed
5.
Kitrou PM, et al. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26(3):348–54.CrossRefPubMed
6.
Katsanos K, et al. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19(2):263–72.CrossRefPubMed
7.
Rasuli P, et al. Randomized trial comparing the primary patency following cutting versus high-pressure balloon angioplasty for treatment of de novo venous stenoses in hemodialysis arteriovenous fistulae. J Vasc Interv Radiol. 2015;26(12):1840–6.CrossRefPubMed
8.
Aftab SA, et al. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. J Vasc Interv Radiol. 2014;25(2):190–8.CrossRefPubMed
9.
Rajan DK, Falk A. A randomized prospective study comparing outcomes of angioplasty versus VIABAHN stent-graft placement for cephalic arch stenosis in dysfunctional hemodialysis accesses. J Vasc Interv Radiol. 2015;26(9):1355–61.CrossRefPubMed
10.
Karnabatidis D, et al. Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study. J Nephrol. 2013;26(2):389–95.CrossRefPubMed
11.
Kitrou P, et al. Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access. Expert Rev Med Devices. 2016;13(12):1119–26.CrossRefPubMed
12.
Dariushnia SR, et al. Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit. J Vasc Interv Radiol. 2016;27(10):1518–30.CrossRefPubMed
13.
Sadaghianloo N, et al. Early surgical thrombectomy improves salvage of thrombosed vascular accesses. J Vasc Surg. 2014;59(5):1377–84.CrossRefPubMed
14.
Prologo JD, et al. Effect of the time to intervention on the outcome of thrombosed dialysis access grafts managed percutaneously. Diagn Interv Radiol. 2014;20(2):143–6.PubMed
15.
Rabin I, et al. Effect of timing of thrombectomy on survival of thrombosed arteriovenous hemodialysis grafts. Vasc Endovascular Surg. 2013;47(5):342–5.CrossRefPubMed
16.
Tordoir JH, et al. Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence? J Vasc Surg. 2009;50(4):953–6.CrossRefPubMed
17.
Vesely TM. Endovascular intervention for the failing vascular access. Adv Ren Replace Ther. 2002;9(2):99–108.CrossRefPubMed
18.
Bermudez P, et al. Endovascular revascularization of hemodialysis thrombosed grafts with the hydrodynamic thrombectomy catheter. our 7-year experience. Cardiovasc Intervent Radiol. 2017;40(2):252–9.CrossRefPubMed
19.
Monsky WL, Latchaw RE. Initial clinical use of a novel mechanical thrombectomy device, XCOILTM, in hemodialysis graft and fistula declot procedures. Diagn Interv Radiol. 2016;22(3):257–62.CrossRefPubMedPubMedCentral
20.
Littler P, et al. AngioJet thrombectomy for occluded dialysis fistulae: outcome data. Cardiovasc Intervent Radiol. 2009;32(2):265–70.CrossRefPubMed
21.
Yang CC, et al. Comparisons of clinical outcomes for thrombectomy devices with different mechanisms in hemodialysis arteriovenous fistulas. Catheter Cardiovasc Interv. 2012;80(6):1035–41.CrossRefPubMed
22.
Dyer J, et al. Aspirex thrombectomy in occluded dialysis access: a retrospective study. Cardiovasc Intervent Radiol. 2016;39(10):1484–90.CrossRefPubMed
23.
Trerotola SO, et al. Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola percutaneous thrombolytic device clinical trial. Radiology. 1998;206(2):403–14.CrossRefPubMed
24.
Cynamon J, et al. Hemodialysis graft declotting: description of the “lyse and wait” technique. J Vasc Interv Radiol. 1997;8(5):825–9.CrossRefPubMed
25.
Gibbens DT, et al. Contemporary treatment of thrombosed hemodialysis grafts. Tech Vasc Interv Radiol. 2001;4(2):122–6.CrossRefPubMed
26.
Vashchenko N, et al. Retrospective comparison of mechanical percutaneous thrombectomy of hemodialysis arteriovenous grafts with the Arrow-Trerotola device and the lyse and wait technique. AJR Am J Roentgenol. 2010;194(6):1626–9.CrossRefPubMed
27.
Goo DE, et al. Thromboaspiration of arteriovenous hemodialysis graft thrombosis using Desilets–Hoffman sheath: single-center experience. J Vasc Access. 2014;15(5):401–8.CrossRefPubMed
28.
Turmel-Rodrigues L, et al. Manual catheter-directed aspiration and other thrombectomy techniques for declotting native fistulas for hemodialysis. J Vasc Interv Radiol. 2001;12(12):1365–71.CrossRefPubMed
29.
Szymski GX, Funaki B. Manual thromboaspiration and dilation of thrombosed dialysis access grafts: mid-term results of a simple concept. J Vasc Interv Radiol. 1998;9(3):517–9.CrossRefPubMed
30.
Bush RL, Lin PH, Lumsden AB. Management of thrombosed dialysis access: thrombectomy versus thrombolysis. Semin Vasc Surg. 2004;17(1):32–9.CrossRefPubMed
31.
Kakkos SK, et al. Percutaneous rheolytic thrombectomy for thrombosed autogenous fistulae and prosthetic arteriovenous grafts: outcome after aggressive surveillance and endovascular management. J Endovasc Ther. 2008;15(1):91–102.CrossRefPubMed
32.
Fan PY, Schwab SJ. Vascular access: concepts for the 1990s. J Am Soc Nephrol. 1992;3(1):1–11.PubMed
33.
Windus DW. Permanent vascular access: a nephrologist’s view. Am J Kidney Dis. 1993;21(5):457–71.CrossRefPubMed
34.
Koukounas V, et al. Incidence of arterial micro-embolization during percutaneous AngioJet thrombectomy of hemodialysis grafts. Cardiovasc Intervent Radiol. 2014;37(2):405–11.CrossRefPubMed
35.
III. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis. 2001;37(1):137–81.
Metadata
Title
Lysis-Assisted Balloon (LAB) Thrombectomy. A Declotting Technique for the Treatment of Thrombosed Arteriovenous Dialysis Grafts. 5-Year Experience of 241 Endovascular Procedures
Authors
Panagiotis M. Kitrou
Panagiotis Papadimatos
Stavros Spiliopoulos
Nicolaos Christeas
Konstantinos Katsanos
Dimitris Karnabatidis
Publication date
01-02-2018
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 2/2018
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-017-1813-z

Other articles of this Issue 2/2018

CardioVascular and Interventional Radiology 2/2018 Go to the issue

Letter to the Editor

Removal of a Stuck Tunneled Central Venous Catheter with the Assistance of Endoluminal Double Balloon Dilatation

Case Report

Delayed Bronchocutaneous Fistula Without Pneumothorax Following a Microwave Ablation of a Recurrent Pulmonary Metastasis

Clinical Investigation

Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma

Case Report

Epidural Balloon Placement for Protection of the Spinal Canal During Cryoablation of Paraspinal Lesions

Letter to the Editor

Reply to the Letter: “Acute Carotid Artery Stent Thrombosis”

Case Report

Tumoral Dissemination Along the Screw Trajectory in Percutaneous Osteosynthesis and Cementoplasty: A Non-described Complication